Cystitis
Cystitis is an infection or inflammation of the bladder, typically presenting with localized symptoms such as suprapubic pain, dysuria, frequency, urgency, and occasionally hematuria, without systemic signs of infection. It is commonly caused by bacterial pathogens, particularly Escherichia coli, and is distinct from chronic conditions like interstitial cystitis. Uncomplicated cystitis is effectively treated with bladder-concentrating antibiotics such as nitrofurantoin and oral fosfomycin. However, no prevention strategies have been scientifically proven to be effective. Treatment during pregnancy is not covered in this context.
References:
-
Cystitis (2)
Tarafenacin D-tartrate
Synonyms: SVT-40776 D-tartrate
- Formula: C25H26F4N2O8
- Molecular Weight: 558.48
Tarafenacin (SVT-40776) D-tartrate is an orally active, selective M3 muscarinic receptor (M3 muscarinic receptor) antagonist with 203-fold selectivity over the M2 muscarinic receptor. Tarafenacin D-tartrate does not affect atrial contraction, arterial blood pressure or arterial pressure at high doses. Tarafenacin D-tartrate can be used in the research of overactive bladder.
Tarafenacin
Cat. No.: HY-14825
CAS No.: 385367-47-5
Synonyms: SVT-40776
- Formula: C21H20F4N2O2
- Molecular Weight: 408.39
Tarafenacin (SVT-40776) is an orally active, selective M3 muscarinic receptor (M3 muscarinic receptor) antagonist with 203-fold selectivity over the M2 muscarinic receptor. Tarafenacin does not affect atrial contraction, arterial blood pressure or arterial pressure at high doses. Tarafenacin can be used in the research of overactive bladder.
